Used for lymphoma: Rituxan (rituximab) was one of the first monoclonals to be used to treat lymphoma having failed chemo. Rituxan (rituximab) which is a mAb targeting CD20, a marker on lymphomas and normal WBC induces ADCC tumor kill on all cells with the markers. Patients manage since the normal WBC's are regenerated in the marrow from precursor cells so count remains normal. Marked improvement in survival of lymphoma now seen.
Answered 7/13/2014
3.9k views
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question